We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| GSK plc | NYSE:GSK | NYSE | Depository Receipt |
| Price Change | % Change | Price | |
|---|---|---|---|
| -0.21 | -0.50% | 41.40 |
| High Price | Low Price | Open Price | Traded | Last Trade |
|---|---|---|---|---|
| 42.03 | 41.42 | 41.75 | 3,672,349 | 01:00:00 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 18/1/2024 | 12:49 | DJN | HilleVax Taps Sean McLoughlin as Chief Operating Officer |
| 17/1/2024 | 09:04 | DJN | Correction to GSK Article on Tuesday |
| 17/1/2024 | 07:44 | DJN | GSK Sells Haleon Shares Valued Around $1.24 Billion Through Discounted.. |
| 16/1/2024 | 17:19 | DJN | GSK to Sell Haleon Shares Worth Around $1.27 Billion |
| 09/1/2024 | 11:37 | DJN | Trending: GSK Buys Asthma-Specialist Aiolos Bio For Up To $1.4 Billion |
| 09/1/2024 | 08:35 | DJN | GSK Expands Respiratory Pipeline With Aiolos Bio Buy -- 2nd Update |
| 09/1/2024 | 08:04 | DJN | GSK Buys Aiolos Bio for Up to $1.4 Billion -- Update |
| 09/1/2024 | 07:39 | DJN | GSK Buys Aiolos Bio for Up to $1.4 Billion |
| 20/12/2023 | 13:27 | DJN | GSK Enters Exclusive License Agreement With Hansoh for HS-20093 Cancer.. |
| 13/11/2023 | 07:49 | DJN | GSK Gets Positive Opinion for Blood Cancer Drug From EU Regulator |
1 Year GSK Chart |
Intraday GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
